4
Changes in Ownership
ANAPTYSBIO, INC Filed Acc 0001209191-19-034870
Chief Medical Officer sold 10,060 shares at an average $73.06 ($734,962)
- Chief Medical Officer acquired 10,060 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Londei Marco · Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-06-04 | Exercise or conversion : show line 1 in the form | +10,060 | $0.70 | $7,042 | 32,437 | D |
| 2019-06-04 | Sale : show line 2 in the form | −6,009 | $72.45 | $435,359 | 26,428 | D |
| 2019-06-04 | Sale : show line 3 in the form | −2,048 | $73.43 | $150,384 | 24,380 | D |
| 2019-06-04 | Sale : show line 4 in the form | −2,003 | $74.50 | $149,219 | 22,377 | D |
| Open-market sales · 10,060 sh · avg $73.06 · $734,962 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-06-04 | Exercise or conversion : show line 5 in the form Employee Stock Option (Right to Buy) | −10,060 | $0.70 | 2024-10-27 | 10,060 | 0 | D |
Loading xslF345X03/doc4.xml…